Supernus Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Supernus Pharma (SUPN) Tops Q1 EPS by 19c
May 9, 2022 4:42 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q1 EPS of $0.43, $0.19 better than the analyst estimate of $0.24. Revenue for the quarter came in at $152 million versus the consensus estimate of $150.47 million.
GUIDANCE:
Supernus Pharma sees FY2023 revenue of $640-680 million, versus the consensus of... More
